InsidersTradesSigma
Track the Gland Pharma Limited share price and the full management transaction log of the company, a listed issuer based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Gland Pharma Limited has published 467 public disclosures. Market capitalisation: €409.5bn. The latest transaction was disclosed on 9 February 2026 (Sale). Among the most active insiders: K. RAGHURAMACHANDRA RAO. All data is free.
467
Insider Decl.
n/a
Thresholds
€4m
78 ops.
Buy Volume
€232m
389 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Gland Pharma Limited Buy (bullish), based on 14 analysts. Average price target: ₹2,286.00.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,236 of 29,063 companies
57.2
score / 100
Value35
Quality79
FCF yld1.1%
Earn yld2.1%
EV/EBITDA25.7x
ROE11%
Gross mgn65%
Net mgn16%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 February 2026
Declarations467 total
100 shares@ ₹1,888.000.8% of flowEquity SharesSEBI:64359e729f8a302301bcd50e60e0d7e8dc054fa1
800 shares@ ₹1,861.004.4% of flowEquity SharesSEBI:9284d4fc50f86c7355e1f6ad615e41666665dda4
306 shares@ ₹1,922.002.4% of flowEquity SharesSEBI:a7470f85ea5c6822c8e9c1f8f1ee31cdca30f082
300 shares@ ₹1,802.81671.7% of flowEquity SharesSEBI:0c553b126afc4d153b330c6987a647a0162b3bca
191 shares@ ₹1,988.89531.7% of flowEquity SharesSEBI:efc2c4d3c37b3f46d910f3dd4bbb5fc27e56bf0c
325 shares@ ₹2,038.002.8% of flowEquity SharesSEBI:e305c9683f76f7bbfe0369f272f40191c57a5a4d
2,800 shares@ ₹542.002.8% of flowEquity SharesSEBI:7219b733f3d9d15f3f9020dbc6a9bb12c9ff8b1e
1,400 shares@ ₹1,807.85715.8% of flowEquity SharesSEBI:e4ea85dcb0fbf1867d673db8b6c041386654c0fb
1,950 shares@ ₹1,810.0010.1% of flowEquity SharesSEBI:7bc39ca3abd0d376443a649a5493d36dee74d5d6
1,950 shares@ ₹1,812.286.7% of flowEquity SharesSEBI:f0701641538c4b901e0b3a0d1fe4eb2e3ab8f5aa
968 shares@ ₹1,825.008.9% of flowEquity SharesSEBI:360d722842482602528dacf731d13346b3e39d4e
2,000 shares@ ₹1,824.9210.5% of flowEquity SharesSEBI:8f689a3055a3a2f0dd127b874064687d16ce52f3
1,000 shares@ ₹1,822.003.4% of flowEquity SharesSEBI:225d8f1f09305affbbab911ef21fc9afb4ad2b81
4,000 shares@ ₹1,825.0020.9% of flowEquity SharesSEBI:a10a415c9823cb6c91b3f02c9247f4863b964dfe
2,250 shares@ ₹1,822.444956.2% of flowEquity SharesSEBI:fca8aec1909c14d829cd7cd4f7382df7f7ad6e0c
1,000 shares@ ₹1,825.003.4% of flowEquity SharesSEBI:8b69af0f66e683207b9cbbeea8ecb5fd725d2aac
3,000 shares@ ₹1,824.0012.4% of flowEquity SharesSEBI:37ea413e40144ed1db5e0c5b8a35488f5749ef0a
1,500 shares@ ₹1,825.002.8% of flowEquity SharesSEBI:4d69956893fe3cff5de43217e94ab6ce1bfb7204
500 shares@ ₹1,817.0560.8% of flowEquity SharesSEBI:605952386b5df2383e2f901adac2a3a3386e1487
13,000 shares@ ₹1,825.337819.8% of flowEquity SharesSEBI:3b73e8629777115c75d3c67c9e4c64c26cb49676
9,900,000 shares@ ₹1,771.813100.0% of flowEquity SharesSEBI:688ec1d79533f8224a9bc66e2dd67a92b03ebb0f
1,456 shares@ ₹1,890.002.8% of flowEquity SharesSEBI:4bb344bcfd94def6e2201a382528b42d88c9f3e7
13,500 shares@ ₹542.006.0% of flowEquity SharesSEBI:a20dc8534285d6623e46638a10a13b5765a0c8dc
25 of 467 declarations
关于 Gland Pharma Limited
Gland Pharma Limited 是一家印度制药公司，专注于注射产品的生产。该公司在孟买证券交易所上市。